SIDS Biomarker Development Grant


In this round of funding, Red Nose is committed to funding AU$100,000 (+GST) over two years to research relating to the development of a Sudden Infant Death (SIDS) biomarker that can be used for population screening.

There has never been a specific biomarker test for SIDS and Red Nose understands that this is the ultimate goal in the fight and prevention of SIDS deaths.

Opening Date: Friday 5th August 2022

Closing Date & Time: Friday 2nd September 2022 at 5.00pm (AEST)

Grant administering entity: Red Nose Limited

Selection Process: Targeted Competitive

Grant Activity Timeframe: October 2022 to October 2024

Total Amount Available (AUD): $100,000 (+GST) over 2 years ($50,000+GSTper year).


Applicants requiring further assistance should direct enquiries to Lacey Fitzgerald, Education and Research Manager – Red Nose on 03 9034 1260, or

Questions should be submitted no later than 5 pm Friday 26th August 2022.

Download our Guideline Document

Download our Application Form